Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders

Transplantation

Volumn 74, Issue 8, 2002, Pages 1090-1095

  Melear, Jason M ^a   Goldstein, Robert M ^a   Levy, Marlon F ^a   Molmenti, Ernesto P ^a   Cooper, Barry ^a   Netto, George J ^a   Klintmalm, Goran B ^a   Stone, Marvin J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYCLOSPORIN; HEPARIN; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PROTHROMBIN; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BONE MARROW EXAMINATION; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CYTOPENIA; FEMALE; FOLLOW UP; GENE MUTATION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; MYELOPROLIFERATIVE DISORDER; ORGAN TRANSPLANTATION; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; SARCOIDOSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 0037184339     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200210270-00006     Document Type: Article

References (31)

1. Shaked A, Goldstein R. Transplantation for Budd-Chiari syndrome. In: Busuttil RW, Klintmalm GB, eds. Transplantation of the Liver. Philadelphia, WB Saunders 1996, pp 138-144.
2. Reynolds TB. Budd-Chiari syndrome. In: Schiff L, Schiff ER, eds. Diseases of the Liver, Ed. 7. Philadelphia, JB Lippincott 1993, pp 1091-1098.
3. Seltman HJ, Dekker A, Van Thiel DH, et al. Budd-Chiari syndrome recurring in a transplanted liver. Gastroenterology 1983; 84: 640-643.
4. Campbell DA Jr, Rolles K, Jamieson N, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988; 166: 511-518.
5. Knoop M, Lemmens HP, Bechstein WO, et al. Treatment of the Budd-Chiari syndrome with orthotopic liver transplantation and long-term anticoagulation. Clin Transplant 1994; 8: 67-72.
6. Dilwari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome): Experience with 177 patients and a review of the literature. Medicine 1994; 73: 21-36.
7. Valla D, Casadelvall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. Ann Intern Med 1985; 103: 329-334.
8. De Stefano V, Teofili L, Leone G, et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23(5): 411-418.
9. Hirshberg B, Shouval D, Fibach E, et al. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol 2000; 32(4): 574-578.
10. Goldstein R, Clark P, Klintmalm G, et al. Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: Treatment with hydroxyurea and aspirin. Transplant Proc 1991; 23(1): 1559-1560.
11. Brunning RD, McKenna RW. Chronic myeloproliferative diseases. Atlas of Tumor Pathology: Tumors of the Bone Marrow. Washington, DC, Armed Forces Institute of Pathology 1993, pp 193-254.
12. Hoffman R, Nimer A, Lanir N, et al. Budd-Chiari syndrome associated with factor V Leiden mutation: A report of 6 patients. Liver Transpl Surg 1999; 5(2): 96-100.
13. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study. Blood 2000; 96(7): 2364-2368.
14. Mahmoud AE, Elias E, Beauchamp N, et al. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798-800.
15. Tan HP, Markowitz JS, Maley WR, et al. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden. Liver Transpl 2000; 6(5): 654-656.
16. Garewal GG, Das R, Chawla Y, et al. Budd-Chiari syndrome associated with homozygous factor V Leiden mutation. Br J Haematol 1999; 105: 842.
17. Leebek FW, Lameris JS, Van Buuren HR, et al. Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by Trends Pharmacol Sci and thrombolysis. Br J Haematol 1998; 102: 929-931.
18. Maddrey W. Hepatic vein thrombosis (Budd-Chiari syndrome): Possible association with the use of oral contraceptives. Semin Liver Dis 1987; 7(1): 32-39.
19. Valla D, Le MG, Poynard T, et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: A case control study. Gastroenterology 1986; 90: 807-811.
20. Oner AF, Arslan S, Caksen H, et al. Budd-Chiari syndrome in a patient heterozygous for both factor V Leiden and the G20210A mutation on the prothrombin gene. Thromb Haemost 1999; 82(4): 1366-1367.
21. Buccairelli P, Franchi F, Alatri A, et al. Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation on the prothrombin gene. Thromb Haemost 1998; 79: 445-446.
22. Nataline MR, Goyette RE, Owensby LC, et al. The Budd-Chiari syndrome in sarcoidosis. JAMA 1978; 239: 2657-2658.
23. Russi EW, Bansky G, Pfaltz M, et al. Budd-Chiari syndrome in sarcoidosis. Gastroenterology 1986; 81(1): 71-75.
24. Mitchell MA, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: Etiology, diagnosis and management. Medicine 1982; 61: 199-218.
25. McDermott WV, Ridker PM. The Budd-Chiari syndrome and hepatic venoocclusive disease: Recognition and treatment. Arch Surg 1990; 125: 525-527.
26. Tsuji H, Murai K, Kobayashi K, et al. Multiple myeloma associated with the Budd-Chiari syndrome. Hepatogastroenterology 1990; 37: 97-99.
27. Junge U, Wienke J, Schuler A. Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency. Z Gastroenterol 2001; 39: 845-852.
28. Espinosa G, Font J, Garcia-Pagan JC, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome. Medicine 2001; 80: 345-354.
29. Halff G, Todo S, Tzakis AG, et al. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990; 211(1): 43-49.
30. Zeitoun G, Escolando S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999; 30: 84-89.
31. Michiels JJ, Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the thrombocythemia vera study group. Semin Thromb Hemost 1997; 23(4): 339-347.